Phio Pharmaceuticals Corp. (PHIO) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Phio Pharmaceuticals Corp. (PHIO) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

PHIO Income Statement

Phio Pharmaceuticals Corp. (PHIO) annual income statement — 15-year revenue, gross profit & net income history

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Sales/Revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	0	1K	1K	1.48M	1.18M	1.07M	15K	985K	644K	866K	1.15M	43K	1.81M	49K	2.13M	1.61M	2.51M	1.3M	1.59M	2.23M
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	-1K	-1K	-1.48M	-1.18M	-1.07M	-15K	-985K	-644K	-866K	-1.15M	-43K	-1.81M	-49K	-2.13M	-1.61M	-2.51M	-1.3M	-1.59M	-2.23M
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	100%	99.91%	93.33%	-49.95%	-83.39%	-24.02%	98.69%	-2190.7%	64.38%	-1667.35%	46.2%	97.34%	27.91%	96.24%	-34.55%	27.46%	6.17%	-	34.71%	-4844.44%
Operating Expenses	4.27M	4.27M	4.17M	1.06M	1.32M	1.24M	1.86M	689K	946K	1.05M	1.06M	1.73M	968K	2.5M	1.47M	1.12M	1.06M	1.22M	1.05M	1.23M
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	1.21M	1.19M	1.37M	1.06M	1.32M	1.24M	986K	689K	946K	1.05M	1.06M	723K	968K	1.16M	1.47M	1.12M	1.06M	1.22M	1.05M	1.23M
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research & Development	3.06M	3.08M	2.79M	1.48M	1.18M	1.07M	886K	985K	644K	866K	1.15M	1.01M	1.81M	1.38M	2.13M	1.61M	2.51M	1.3M	1.59M	2.23M
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	-1000K	-1000K	-1000K	-15K	-985K	-644K	-866K	-1000K	0	-1000K	-49K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K
Operating Income	0	-4.27M	-4.17M	-2.53M	-2.5M	-2.31M	-1.87M	-1.67M	-1.59M	-1.91M	-2.21M	-1.77M	-2.78M	-2.55M	-3.6M	-2.73M	-3.57M	-2.52M	-2.64M	-3.45M
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	100%	-84.84%	-122.6%	-51.37%	-57.55%	-20.64%	15.26%	5.58%	42.72%	24.85%	38.67%	35.05%	22.26%	-1.03%	-36.44%	20.87%	4.49%	6.07%	27.43%	-40.13%
EBITDA	0	-4.27M	-4.17M	-2.53M	-2.5M	-2.31M	-1.77M	-1.63M	-1.52M	-1.91M	-2.17M	-1.73M	-2.76M	-2.53M	-3.59M	-2.71M	-3.56M	-2.5M	-2.62M	-3.43M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	100%	-84.84%	-135.5%	-55.21%	-64.24%	-20.67%	18.67%	5.66%	44.8%	24.45%	39.35%	36.28%	22.36%	-1.2%	-36.97%	20.85%	4.41%	6.15%	27.68%	-41.91%
D&A (Non-Cash Add-back)	0	1K	1K	1K	2K	500	0	42K	0	1K	34K	43K	15K	15K	16K	15K	15K	19K	22K	20K
EBIT	0	-4.27M	-4M	-2.37M	-2.39M	-2.17M	-1.77M	-1.63M	-1.52M	-1.85M	-2.15M	-1.9M	-2.78M	-2.55M	-3.6M	-2.73M	-3.57M	-2.52M	-2.64M	-3.45M
Net Interest Income	0	130K	161K	0	0	119K	125K	231K	0	0	0	0	0	0	0	0	-5K	-10K	-2K	-1K
Interest Income	0	130K	161K	0	0	119K	125K	231K	0	0	0	0	0	0	0	0	0	0	0	0
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5K	10K	2K	1K
Other Income/Expense	0	130K	164K	163K	113K	143K	103K	48K	66K	68K	55K	-122K	-4K	-2K	0	-1K	-5K	-10K	-2K	-1K
Pretax Income	-4.16M	-4.14M	-4M	-2.37M	-2.39M	-2.17M	-1.77M	-1.63M	-1.52M	-1.85M	-2.15M	-1.9M	-2.78M	-2.55M	-3.6M	-2.73M	-3.58M	-2.53M	-2.64M	-3.45M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-4.16M	-4.14M	-4M	-2.37M	-2.39M	-2.17M	-1.77M	-1.63M	-1.52M	-1.85M	-2.15M	-1.9M	-2.78M	-2.55M	-3.6M	-2.73M	-3.58M	-2.53M	-2.64M	-3.45M
Net Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-73.91%	-91.04%	-126.29%	-45.82%	-56.96%	-17.33%	17.87%	14.2%	45.18%	27.58%	40.2%	30.61%	22.26%	-0.71%	-36.34%	20.86%	4.44%	5.81%	22.45%	-40.17%
Net Income (Continuing)	-4.16M	-4.14M	-4M	-2.37M	-2.39M	-2.17M	-1.77M	-1.63M	-1.52M	-1.85M	-2.15M	-1.9M	-2.78M	-2.55M	-3.6M	-2.73M	-3.58M	-2.53M	-2.64M	-3.45M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.36	-0.36	-0.34	-0.20	-0.44	-0.45	-41070.15	-0.37	-1.54	-3.62	-4.24	-4.56	-10.26	-13.29	-28.41	-20.52	-28.33	-20.11	-21.07	-27.57
EPS Growth %	18.18%	20%	100%	45.95%	71.43%	87.57%	-	91.89%	84.99%	72.76%	85.08%	77.78%	63.78%	33.91%	-34.84%	25.57%	5.22%	6.29%	38.91%	40.13%
EPS (Basic)	-0.36	-0.36	-0.34	-0.20	-0.44	-0.45	-41070.15	-0.37	-1.54	-3.62	-4.24	-4.56	-10.26	-13.29	-28.41	-20.52	-28.33	-20.11	-21.07	-27.57
Diluted Shares Outstanding	11.69M	11.62M	11.62M	11.62M	5.47M	4.79M	4.31M	787.47K	990.03K	510.19K	508.39K	415.95K	270.86K	191.86K	126.78K	126.43K	126.38K	126.34K	125.47K	125.19K
Basic Shares Outstanding	11.69M	11.62M	11.62M	11.62M	5.47M	4.79M	4.31M	787.47K	990.03K	510.19K	508.39K	415.95K	270.86K	191.86K	126.78K	126.43K	126.38K	126.34K	125.47K	125.19K
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-